Greiner Alexander N MD is categorized under Physicians Offices in San Diego, CA and active since 2004.
Greiner Alexander N MD was established in 2004, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Alexander Greiner at the company’s single location by writing to 5776 Ruffin Road, San Diego, California CA 92123 or by phoning (858) 292-1144. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Greiner Alexander N MD |
| Contact Person: | Alexander Greiner |
| Address: | 5776 Ruffin Road, San Diego, California 92123 |
| Phone Number: | (858) 292-1144 |
| Website Address: | allergyandasthma.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physicians Offices |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Greiner Alexander N MD was started in 2004 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Alexander Greiner for inquiries that concern Greiner Alexander N MD by calling the company number (858) 292-1144, as your correspondence is most welcome. Additionally, the physical location of the single location of Greiner Alexander N MD can be found at the coordinates 32.83939,-117.12747 as well as the street address 5776 Ruffin Road in San Diego, California 92123.
For its online presence, you may visit Greiner Alexander N MD’s website at allergyandasthma.com and engage with its social media outlets through on Twitter and on Facebook.